BioSpace News Archive

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for the third quarter ended September 30, 2021 and provided corporate updates.

Imbed Biosciences, Inc. (Imbed) announced today that it has been awarded a contract for $1,999,481 by the U.S. Army Medical Research and Development Command’s (USAMRDC) Military Infectious Diseases Research Program (MIDRP) to accelerate clinical development of an antibiofilm version of its next-generation Microlyte® Matrix wound dressing that can kill bacteria hidden in biofilms.

Kaleido Biosciences, Inc. today announced the appointment of Alison Long, M.B.B.Ch., Ph.D., to its leadership team as Chief Medical Officer, effective December 15, 2021.

Monte Rosa Therapeutics, Inc. today reported business highlights and financial results for the third quarter, ended Sept. 30, 2021.

Decibel Therapeutics today reported financial results for the third quarter ended September 30, 2021 and provided a corporate update.

Century Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates. Research and development update to be held on Thursday, December 16, 8:00-9:30 AM EST

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced financial results for the third quarter ended September 30, 2021 and provided a business update.

SCYNEXIS Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Vial also known as phial or flacon, is a small plastic or a glass bottle or vessel. Vials are primarily used to store medication such as powders, liquids or capsules.

According to the report, the global intravascular ultrasound devices market was valued at US$ 600 Mn in 2020.